Missing the target for routine human papillomavirus vaccination: Consistent and strong physician recommendations are lacking for 11- to 12-year-old males

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 10, 2016, Pages 1435-1446

  Vadaparampil, Susan T ^a,b   Malo, Teri L ^c   Sutton, Steven K ^a,b   Ali, Karla N ^a   Kahn, Jessica A ^d   Casler, Alix ^e   Salmon, Daniel ^f   Walkosz, Barbara ^g   Roetzheim, Richard G ^a,b   Zimet, Gregory D ^h   Giuliano, Anna R ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e ORLANDO HEALTH   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g Klein Buendel   (United States)

^h INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; FAMILY MEDICINE; FEMALE; FLORIDA; FOLLOW UP; GENERAL PRACTICE; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNITED STATES; VACCINATION; WART VIRUS; ATTITUDE TO HEALTH; CHILD; CLINICAL PRACTICE; PROTOCOL COMPLIANCE; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; FEMALE; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS VACCINES; PRACTICE PATTERNS, PHYSICIANS'; SURVEYS AND QUESTIONNAIRES; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84990041233     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-1294     Document Type: Article

References (55)

1. Centers for Disease Control and Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1705-8.
2. Petrosky E, Bocchini JAJr, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2015;64:300-4.
3. Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2014. MMWR Morb Mortal Wkly Rep 2015;64:784-92.
4. Cullen KA, Stokley S, Markowitz LE. Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012. Acad Pediatr 2014;14:497-504.
5. Centers for Disease Control and Prevention. Human papillomavirus (HPV)-associated cancers, by anatomic site and state - United States, 2004-2008. Available from: http://www.cdc.gov/cancer/hpv/pdf/HPV-state-rates.pdf.
6. Giuliano AR, Palefsky JM, Goldstone S, Moreira EDJr, Penny ME, Aranda C, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011;364:401-11.
7. Palefsky JM, Giuliano AR, Goldstone S, Moreira EDJr, Aranda C, Jessen H, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011;365:1576-85.
8. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113:3036-46.
9. Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. BMC Cancer 2013;13:10.
10. Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers - United States, 2004-2008. MMWRMorb Mortal Wkly Rep 2012;61:258-61.
11. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012;13:487-500.
12. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004;101:270-80.
13. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13-17 years - United States, 2011. MMWR Morb Mortal Wkly Rep 2012;61:671-7.
14. Brewer NT, Croyle R. President's Cancer Panel: achieving widespread HPV vaccine uptake. Bethesda, MD: National Cancer Institute; 2012.
15. McRee AL, Gilkey MB, Dempsey AF. HPV vaccine hesitancy: findings from a statewide survey of health care providers. J Pediatr Health Care 2014;28:541-9.
16. Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev 2015;24:1673-9.
17. Soon R, Dela Cruz MR, Tsark JU, Chen JJ, Braun KL. A survey of physicians' attitudes and practices about the human papillomavirus (HPV) vaccine in Hawai'i. Hawaii J Med Public Health 2015;74:234-41.
18. Allison MA, Hurley LP, Markowitz L, Crane LA, Brtnikova M, Beaty BL, et al. Primary care physicians' perspectives about HPV vaccine. Pediatrics 2016;137:1-9.
19. Jaen CR, Stange KC, Nutting PA. Competing demands of primary care: a model for the delivery of clinical preventive services. J Fam Pract 1994;38:166-71.
20. Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011;29:8634-41.
21. Vadaparampil ST, Malo TL, Kahn JA, Salmon DA, Lee JH, Quinn GP, et al. Physicians' human papillomavirus vaccine recommendations, 2009 and 2011. Am J Prev Med 2014;46:80-4.
22. Vadaparampil ST, Staras SAS, Malo TL, Eddleton KZ, Christie J, Rodriguez M, et al. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls. Cancer 2013;119:621-8.
23. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010;126:425-33.
24. Rimer B, Harper H, Witte ON. Accelerating HPV vaccine u: urgency for action to prevent cancer. A report to the President of the United States from the President's Cancer Panel. Bethesda, MD: National Cancer Institute; 2014.
25. Freed GL, Nahra TA, Wheeler JR. Counting physicians: inconsistencies in a commonly used source for workforce analysis. Acad Med 2006;81:847-52.
26. Kletke PR. Physician workforce data: when the best is not good enough. Health Serv Res 2004;39:1251-5.
27. Dillman D. Mail and internet surveys: the tailored design method. New York, NY: Wiley; 2000.
28. Kahn JA, Zimet GD, Bernstein DI, Riedesel JM, Lan D, Huang B, et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 2005;37:502-10.
29. Riedesel JM, Rosenthal SL, Zimet GD, Bernstein DI, Huang B, Lan D, et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 2005;18:391-8.
30. Kahn JA, Rosenthal SL, Tissot AM, Bernstein DI, Wetzel C, Zimet GD. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr 2007;7:367-73.
31. Daley MF, Liddon N, Crane LA, Beaty BL, Barrow J, Babbel C, et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics 2006;118:2280-9.
32. Malo TL, Giuliano AR, Kahn JA, Zimet GD, Lee JH, Zhao X, et al. Physicians' human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients: a national study. Cancer Epidemiol Biomarkers Prev 2014;23:2126-35.
33. Allison MA, Dunne EF, Markowitz LE, O'Leary ST, Crane LA, Hurley LP, et al. HPV vaccination of boys in primary care practices. Acad Pediatr 2013;13:466-74.
34. Malo TL, Ali KN, Sutton SK, Perkins RB, Giuliano AR, Vadaparampil ST. The content and context of physicians' communication with males about human papillomavirus vaccination. Hum Vaccin Immunother 2016;12:1511-8.
35. Scherr CL, Augusto B, Ali K, Malo TL, Vadaparampil ST. Provider-reported acceptance and use of the Centers for Disease Control and Prevention messages and materials to support HPV vaccine recommendation for adolescent males. Vaccine 2016;34:4229-34.
36. U.S. Department of Health and Human Services. Healthy People 2020. 2014[cited 2014 Jul 1]. Available from: http://healthypeople.gov/2020/topicsobjectives2020/pdfs/HP2020objectives.pdf.
37. Ko EM, Missmer S, Johnson NR. Physician attitudes and practice toward human papillomavirus vaccination. J Low Genit Tract Dis 2010;14:339-45.
38. Gilkey MB, McRee AL. Provider communication about HPV vaccination: a systematic review. Hum Vaccin Immunother 2016:12:1454-68.
39. Gollust SE, LoRusso SM, Nagler RH, Fowler EF. Understanding the role of the news media in HPV vaccine uptake in the United States: synthesis and commentary. Hum Vaccin Immunother 2016;12:1430-4.
40. Krakow M, Rogers B. Collateral damage and critical turning points: public health implications of HPV vaccine news coverage for boys and men in 2011. Health Commun 2016;31:1081-8.
41. Dornbusch HJ, Stiris T, Del Torso S, Ross-Russell R, Zavrsnik J, Wettergren B, et al. Human papillomavirus vaccination crisis in Japan. J Paediatr Child Health 2015;51:1146-7.
42. Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet 2015;385:2571.
43. Kempe A, Patel MM, Daley MF, Crane LA, Beaty B, Stokley S, et al. Adoption of rotavirus vaccination by pediatricians and family medicine physicians in the United States. Pediatrics 2009;124:e809-16.
44. Bratic JS, Seyferth ER, Bocchini JAJr. Update on barriers to human papillomavirus vaccination and effective strategies to promote vaccine acceptance. Curr Opin Pediatr 2016;28:407-12.
45. Reiter PL, Gilkey MB, Brewer NT. HPV vaccination among adolescent males: results from the National Immunization Survey-Teen. Vaccine 2013;31:2816-21.
46. Ruffin MTIV, Plegue MA, Rockwell PG, Young AP, Patel DA, Yeazel MW. Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion. J Am Board Fam Med 2015;28:324-33.
47. Oliver K, Frawley A, Garland E. HPV vaccination: population approaches for improving rates. Hum Vaccin Immunother 2016;12:1589-93.
48. Jacobson RM, Agunwamba AA, St Sauver JL, Finney Rutten LJ. The most effective and promising population health strategies to advance human papillomavirus vaccination. Expert Rev Vaccines 2016;15:257-69.
49. Centers for Disease Control and Prevention. VFC:for parents.2012. Available from: http://www.cdc.gov/vaccines/programs/vfc/parents/qa-detailed.html.
50. Lee GM, Santoli JM, Hannan C, Messonnier ML, Sabin JE, Rusinak D, et al. Gaps in vaccine financing for underinsured children in the United States. J Am Med Assoc 2007;298:638-43.
51. Davis MM, Ndiaye SM, Freed GL, Clark SJ. One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians. J Am Board Fam Pract 2003;16:363-71.
52. Mennito SH, Darden PM. Impact of practice policies on pediatric immunization rates. J Pediatr 2010;156:618-22.
53. Centers for Disease Control and Prevention. VFC healthcare providers information flyer. 2014; Available from: http://www.cdc.gov/vaccines/programs/vfc/providers/questions/qa-flyer-hcp.html.
54. Centers for Disease Control and Prevention. HPV vaccine resources for healthcare Professionals. 2015; Available from: http://www.cdc.gov/vaccines/who/teens/for-hcp/hpv-resources.html.
55. American Academy of Pediatrics. HPV Champion Toolkit. 2015. Available from: https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/Pages/HPV-Champion-Toolkit.aspx.